XT
DMRA

XTX Topco’s Damora Therapeutics, Inc. Ordinary Shares DMRA Stock Holding History

XTX Topco’s Portfolio DMRA Stock Details DMRA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$252K Buy
+9,728
New +$250K ﹤0.01% 2635
2024
Q2 		– Sell
-730
Closed -$14.2K – 2084
2024
Q1 		$14.2K Buy
+730
New +$13K ﹤0.01% 1641
2023
Q4 		– Sell
-692
Closed -$12.5K – 1774
2023
Q3 		$12.5K Buy
+692
New +$27.2K ﹤0.01% 1414
2021
Q3 		– Sell
-441
Closed -$56K – 811
2021
Q2 		$56K Buy
+441
New +$60.1K 0.02% 721

Other funds holding DMRA

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
FFM
Fairmount Funds Management West Conshohocken, Pennsylvania $1.38B AUM 407.79% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
VA
VR Adviser New York $2.68B AUM 422.73% 1-Year Est. Return
FIS
FCPM III Services Naarden, Netherlands $722M AUM 73.61% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.7B AUM 21.3% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return
RCP
Remedium Capital Partners Fort Lauderdale, Florida $281M AUM

XTX Topco's DMRA Position: Q1 2026 in Review

XTX Topco opened a new position in Damora Therapeutics, Inc. Ordinary Shares (DMRA) in Q1 2026: 9,728 shares worth $252K. The stake represents ﹤0.01% of the portfolio and ranks #2635 among its holdings. This is a return to the name: XTX Topco previously reported a position in DMRA as recently as Q1 2024.

XTX Topco first reported a position in DMRA in Q2 2021 and has held it in 4 quarters since. 65 funds tracked by Wall St. Rank hold DMRA as of Q1 2026.

  • XTX Topco held 9,728 shares of Damora Therapeutics, Inc. Ordinary Shares worth $252K as of Q1 2026.
  • Damora Therapeutics, Inc. Ordinary Shares was a new XTX Topco position in Q1 2026.
  • Damora Therapeutics, Inc. Ordinary Shares made up ﹤0.01% of XTX Topco's portfolio in Q1 2026, its #2635 holding.
  • XTX Topco first reported a position in Damora Therapeutics, Inc. Ordinary Shares in Q2 2021 and has held it in 4 quarters since.
  • 65 funds tracked by Wall St. Rank held Damora Therapeutics, Inc. Ordinary Shares as of Q1 2026.

Based on XTX Topco's 13F filing for Q1 2026, filed 15 May 2026.